1. Home
  2. EHTH vs HBIO Comparison

EHTH vs HBIO Comparison

Compare EHTH & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eHealth Inc.

EHTH

eHealth Inc.

HOLD

Current Price

$4.61

Market Cap

128.9M

Sector

Finance

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$0.66

Market Cap

33.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
EHTH
HBIO
Founded
1997
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
128.9M
33.8M
IPO Year
2006
2000

Fundamental Metrics

Financial Performance
Metric
EHTH
HBIO
Price
$4.61
$0.66
Analyst Decision
Buy
Buy
Analyst Count
3
3
Target Price
$8.67
$2.50
AVG Volume (30 Days)
396.8K
598.2K
Earning Date
11-05-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.04
N/A
Revenue
$542,951,000.00
$87,371,000.00
Revenue This Year
$4.61
N/A
Revenue Next Year
N/A
$7.22
P/E Ratio
$102.78
N/A
Revenue Growth
16.79
N/A
52 Week Low
$3.18
$0.28
52 Week High
$11.36
$2.28

Technical Indicators

Market Signals
Indicator
EHTH
HBIO
Relative Strength Index (RSI) 56.97 44.94
Support Level $4.01 $0.71
Resistance Level $5.35 $0.80
Average True Range (ATR) 0.35 0.05
MACD 0.04 -0.02
Stochastic Oscillator 52.20 6.90

Price Performance

Historical Comparison
EHTH
HBIO

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: